| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,887 |
3,738 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,730 |
1,286 |
$26K |
| 99215 |
Prolong outpt/office vis |
511 |
412 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
562 |
445 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
448 |
381 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
63 |
53 |
$3K |
| 0002A |
|
175 |
149 |
$2K |
| 0001A |
|
187 |
150 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
2,794 |
2,124 |
$554.15 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
130 |
104 |
$498.84 |
| 99442 |
|
113 |
81 |
$424.72 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
34 |
28 |
$205.32 |
| 0003A |
|
26 |
17 |
$40.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
35 |
28 |
$11.00 |
| 91300 |
|
432 |
311 |
$1.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
14 |
13 |
$0.00 |
| 90688 |
|
19 |
15 |
$0.00 |
| 0011A |
|
19 |
16 |
$0.00 |
| 91301 |
|
54 |
43 |
$0.00 |
| 0012A |
|
20 |
17 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
15 |
14 |
$0.00 |